ZARR

News and price dashboard

1 unreachable
Sources
27, 1 unreachable
Items
49130
Flagged
5820
Last swept
19:36

STOCKS

120

OPTIONS

25

COMING UP

US majors and your names' earnings, next 7 days

Full calendar

Everything else — unscored, browse only, never pushed

Brief

Bank earnings day, mixed results

The biggest single theme in the feed is the start of Q3 bank reporting. Wells Fargo, covered in full, slipped 1.6% pre-open: net income of $6.0 billion or $1.87 a share was up 13% year over year and a touch above consensus, but revenue of $21.87 billion missed by roughly $440 million, with the shortfall in capital markets and Corporate and Investment Banking, and the Corporate segment posting a loss where income was expected. Net interest income of $12.52 billion also came in light, though management held full-year NII guidance and guided to about $13 billion for Q4. Consumer, Commercial and Wealth all beat. A HUD probe into past mortgage lending programs has been hanging over the name. Alongside that, headline-only items say Goldman Sachs beat by $3.92 with revenue above estimates and profit rising on equities strength, Citi's profit jumped 40% on investment banking, services and wealth, and JPMorgan shares fell as profit missed and fixed-income trading disappointed. Bank of America, Morgan Stanley and BlackRock report Wednesday.

BioNTech trial miss

BioNTech fell nearly 6% pre-open after its mRNA cancer immunotherapy BNT113 failed the first of two dual primary endpoints, progression-free survival, in the AHEAD-MERIT Phase 2/3 trial in unresectable recurrent or metastatic HPV16-positive head and neck squamous cell carcinoma. The trial tested BNT113 plus pembrolizumab against pembrolizumab alone first-line, and the PFS improvement was not statistically significant at this interim look. CMO Özlem Türeci said the data support continued evaluation and show the drug is engaging its intended mechanism. The second dual primary endpoint, overall survival, is still outstanding. The article notes this lands on top of existing uncertainty: co-founders Ugur Sahin and Türeci plan to leave by the end of 2026 to start an independent venture, Sahin's direct shareholding has gone to zero with his stake now held indirectly, and Morgan Stanley had previously trimmed its target. Shares were at $90.15 against a prior close of $95.84, nearer the $79.52 52-week low than the $124 high.

VF upgraded twice on Vans

VF Corp rallied 3.9% pre-open on two upgrades. Piper Sandler went to Overweight from Neutral with a $20 target, up from $16, citing its Fall Teen Survey of roughly 9,000 respondents showing Vans holding a top footwear spot among males and ending a multi-survey decline, plus gains among upper-income male teens. Truist moved to Buy from Hold and nearly doubled its target to $20 from $14, arguing fashion is rotating away from athletic looks and retailers are filling shelf space vacated by Nike lifestyle pullbacks. A JPMorgan upgrade to Neutral the prior session had already helped. Stifel stayed at Hold with a $17 target, flagging Vans wholesale orders as the swing factor. Separately in the feed, a headline-only Piper note says Nike continues to lose teen share as On Running gains, which fits the same survey work.

Domino's beats but comps stall

Domino's fell 3.1% pre-open despite beating on both lines, with diluted EPS of $4.60 against roughly $4.36 expected and revenue of $1.185 billion. The problem was US same-store sales up just 0.3%, down from 5.3% franchise comp growth a year earlier, plus year-to-date operating cash flow off 5.7% to $520.6 million and free cash flow down 7.2% to $459.8 million. It was the first earnings call under new CEO Joe Jordan. Morgan Stanley had cut its target to $357 from $370 the day before, keeping Equalweight and citing category and TAM concerns, quick-service softness and rising rates. The stock sits about 32% below its $442.35 52-week high.

J&J beats on EPS, devices drag

Johnson & Johnson slid 2.5% pre-open. Adjusted EPS of $2.59 beat the $2.53 consensus and revenue of $25.4 billion was slightly ahead and up 5.9%, but GAAP EPS was just $0.09 and GAAP net earnings fell 95.9% to $210 million, reflecting a one-time charge for the proposed talc litigation resolution, the Firefly Bio acquisition and the Sail Biomedicines collaboration. Pharma sales rose 7.7% to $16.76 billion while medtech rose only 2.5% to $8.6 billion, flat outside the US, with the article attributing the weakness to geopolitical issues. Full-year adjusted EPS guidance was raised to $11.05 to $11.15 against $11.08 consensus. The proposed $5.5 billion talc settlement remains conditional on claimant acceptance. The piece notes zero positive and 12 negative EPS revisions in the last 90 days.

Visa gets China clearing approval

Visa rose 1.4% pre-open after the People's Bank of China approved Visa Information Technology (Beijing) to begin formal preparations for a domestic bankcard clearing institution. Visa has up to a year to complete preparations before applying for a full operating licence. CEO Ryan McInerney called it a significant step forward. Mastercard and American Express already hold similar approvals. Baird raised its target to $430 from $420 on Monday with an Outperform rating ahead of fiscal Q4 results on October 27, expecting a modest beat but some growth deceleration into fiscal 2027. The stock set a 52-week high of $391.81 in the prior session and traded to $394.83 pre-market.

Chips, oil and the macro backdrop

The session's wider tone, per the TSX futures piece, was a split tape: Dow futures up, Nasdaq futures down 0.7%, chipmakers under pressure with the industry tracker off 2.7% on Monday and Korean tech hit too, partly on reports of advances by China's ChangXin Memory Technologies narrowing the AI gap. Vital Knowledge noted the debate is why tech has traded so poorly for several sessions. Oil fell after Russia said diesel exports may exceed the volumes in its supply deal with the US, pulling back from Monday's spike that followed Houthi strikes on Saudi infrastructure; gold rebounded. September CPI lands Wednesday, with the Fed expected to hold this month after September's hike. Headline-only items round this out: OPEC raised its 2027 demand growth forecast to 2.55M bpd while cutting 2026 to 180,000 bpd, Saudi production reportedly at about 8.4M b/d in September, the Houthis warning Riyadh of a harsh response, the Kremlin denying the diesel deal is linked to Ukraine talks, and a BofA poll showing tech overweight at its highest since August 2020.

Analyst notes and smaller company items

Mizuho raised Energy Transfer to $26 from $25 with an Outperform rating, expecting commodity earnings to moderate from strong Q2 2026 levels but staying constructive; the note cites the Vaquero acquisition expanding the Delaware footprint as a strategically sensible if pricey bolt-on, projects ramping, and the Waha price recovery reducing optimisation gains. The stock was $20.41, up 30.41% year to date with a 6.66% yield. Needham lifted SentinelOne to $31 from $26, keeping Buy, after a pre-quiet-period conversation convinced it the three emerging products, now over half of total ARR, are not cannibalising endpoint; net revenue retention is back above 110% and revenue grew 21% to $1.1 billion over twelve months. Note the tension in the feed: separate headline-only items say SentinelOne fell 7% after announcing a $1.25 billion convertible notes offering. Dauch Corporation named Nathan Iles CFO effective December 1, joining as SVP Finance on November 2, succeeding Christopher May who becomes EVP and Chief Administrative Officer overseeing IT and HR; Iles was most recently CFO at Standard Motor Products. A long tail of other analyst headlines sits in the list without detail, including Northland cutting Enovix on silicon anode delays, Mizuho cutting Enlight on valuation, Wells Fargo cutting Bristol-Myers on Eliquis concerns, Jefferies initiating Electra at Buy, and Deutsche Bank raising its outlook on semiconductor equipment.

Noise in the feed

A large share of the 200 items is retail chart commentary from TradingView on gold, EURUSD, Bitcoin and index futures, which is directional opinion rather than news, plus routine SEC Form 4 and Form 144 filings with no accompanying detail. Two Trump Truth Social posts were read in full and contain no market content: both are reposts of other users' screenshots, one about Mike Tyson and loyalty, the other a Fox commentary clip about midterm campaigning.

20 read in full, 200 items in the section

Feed

158 stories · 96 newCross-publisher stories only
  1. Pinned
  2. 96 new
  3. XRP — Bearish Outlook
    TradingView [COMMENT]
  4. NAS100 Sell/Short Setup (30M)
    TradingView [COMMENT]
  5. Urban Outfitters stock hits all-time high at 85.44 USD
    Investing.com - UK 8 itemsalso Investing.com - news
  6. New invoice is ready.
    TradingView [COMMENT]
  7. Quarterly Head & Shoulders
    TradingView [COMMENT]
  8. SOL/USDT — Bearish Outlook | 97
    TradingView [COMMENT]
  9. KLA-Tencor, Caterpillar among market cap stock movers on Tuesday
    Investing.com - news 2 itemsalso Investing.com - UK
  10. Nvidia invests in four French technology startups, Les Echos reports
    Investing.com - news 2 itemsalso Investing.com - news
  11. Uniti Solutions launches AI security service with Cato Networks
    Investing.com - news 2 itemsalso Investing.com - UK
  12. GOLD Bearish Breakout!
    TradingView [COMMENT]
  13. $NEAR | 4H | BUY SETUP |
    TradingView [COMMENT] 2 itemsalso TradingView
  14. India regulator proposes tighter rules for equity fundraising
    Investing.com - news 2 itemsalso Investing.com - UK
  15. Form 144 BLUE BIOFUELS For: 13 October
    Investing.com - UK 4 items
  16. Form 4 Lattice Semiconductor Corporation: Pravin Desale (SVP, R&D) For: 10 October
    Investing.com - UK 3 itemsalso Investing.com - UK
  17. Why is Applied Materials stock sliding today?
    Investing.com - news 36 itemsalso Investing.com - UK
  18. $ARM - buy setup soon
    TradingView [COMMENT]
  19. Holding support
    TradingView [COMMENT]
  20. Applied Materials at semicon west 2026: ai buildout drives growth
    Investing.com - news 2 itemsalso Investing.com - UK
  21. Tuesday 10/13 Insider Buying Report: IMSR, NEOG
    Nasdaq - stocks 2 items
  22. SPARC
    TradingView [COMMENT]
  23. ZEC will continue to crash through Nov-Dec
    TradingView [COMMENT]
  24. Tuesday's ETF with Unusual Volume: LSGR
    Nasdaq - stocks
  25. Tuesday's ETF Movers: CRAK, SLVR
    Nasdaq - stocks
  26. Ivory Coast Harvest Delays Boost Cocoa Prices
    Nasdaq - stocks 3 items
  27. XAUUSD SELL SHIORT
    TradingView [COMMENT]
  28. Arm shares fall after jury rules in favor of Qualcomm in license dispute
    Investing.com - news 2 itemsalso Investing.com - UK
  29. What is The Triangle of Power
    TradingView [COMMENT] 2 itemsalso TradingView
  30. Uttam Sugar Mills
    TradingView [COMMENT]
  31. Centene Corp stock hits 52-week high at 69.64 USD
    Investing.com - UK 4 itemsalso Investing.com - news
  32. AMD Seeking its 1D MA200 at $460.
    TradingView [COMMENT]
  33. Form 4 Fundrise Income Real Estate Fund: Mark David Monte (Director) For: 9 October
    Investing.com - UK 4 itemsalso Investing.com - UK
  34. Why is Vertex Pharmaceuticals stock sliding 4% today?
    Investing.com - news 2 itemsalso Investing.com - UK
  35. ADS to acquire StormTrap for $530 million from PSP Capital
    Investing.com - news 2 itemsalso Investing.com - UK
  36. Why is Molina Healthcare stock up 3.5% today?
    Investing.com - UK 2 itemsalso Investing.com - news
  37. Dow reverses to create potential bear signal
    TradingView [COMMENT]
  38. An Investor's Earnings Almanac For Q4
    Schaeffer's Research [COMMENT]
  39. Why is First Solar stock gaining 3.5% today?
    Investing.com - UK 2 itemsalso Investing.com - news
  40. Why is International Flavors & Fragrances stock up 4% today?
    Investing.com - UK 2 itemsalso Investing.com - news
  41. Why is Erie Indemnity stock rallying 3% today?
    Investing.com - UK 34 itemsalso Investing.com - news, Investing.com - UK
  42. How This Rare Options Strategy Might Work On AMD Stock
    Investor's Business Daily
  43. S&P 500 Analyst Moves: PANW
    Nasdaq - stocks
  44. Seen
  45. Why is Keysight Technologies stock sliding today?
    Investing.com - UK 3 itemsalso Investing.com - news
  46. Tata Technologies
    TradingView [COMMENT]
  47. Bank Stock Facing Chart Pressure Before Earnings
    Schaeffer's Research [COMMENT]
  48. Kalyan Jewellers
    TradingView [COMMENT]
  49. $CRM: $225 Support Holds, $285 Remains My Target
    TradingView [COMMENT]
  50. XAGUSD TRADE IDEA
    TradingView [COMMENT]
  51. B L KASHYAP
    TradingView [COMMENT]
  52. Jefferies examines HealthEquity stock short interest rise
    Investing.com - news 2 itemsalso Investing.com - UK
  53. Marsh names Nicole Delimitros to lead employee benefits unit
    Investing.com - news 2 itemsalso Investing.com - UK
  54. Eurusd
    TradingView [COMMENT]
  55. Stocks Decline as Chipmakers Retreat
    Nasdaq - stocks
  56. Strong Short Setup
    TradingView [COMMENT]
  57. Form 4 Halliburton For: 13 October
    Investing.com - UK 4 itemsalso Investing.com - UK
  58. POTENTIAL BULLISH REVERSAL
    TradingView [COMMENT]
  59. Goldman Sachs earnings analysis: questions answered and next catalysts
    Investing.com - news 3 itemsalso Investing.com - UK
  60. Taysha Gene Therapies stock hits 52-week low at 3.69 USD
    Investing.com - news 2 itemsalso Investing.com - UK
  61. bajaj finserv
    TradingView [COMMENT]
  62. Nas100 BUY
    TradingView [COMMENT]
  63. JNJ: Raised Guidance, Broken Trend
    TradingView [COMMENT]
  64. BTC London session: bid wall at 83,389 pulled
    TradingView [COMMENT]
  65. Mettler-Toledo stock hits 52-week high at 1586.0 USD
    Investing.com - news 9 items
  66. XAUUSD GOLD SELL SETUP | 4H BEARISH CONTINUATION
    TradingView [COMMENT]
  67. GOLD 1H CHART - MARKET ROUTE MAP
    TradingView [COMMENT] 2 items
  68. Ethereum Wave Analysis – 13 October 2026
    TradingView [COMMENT] 6 itemsalso TradingView
  69. THE KOG REPORT - Update
    TradingView [COMMENT]
  70. Head and Shoulder formation on Bitcoin 1D
    TradingView [COMMENT]
  71. Don't Sweat ON Semiconductor Stock's Recent Pullback
    Schaeffer's Research [COMMENT]
  72. BEL
    TradingView [COMMENT]
  73. WTI Crude Oil – Wolfe Wave Pattern Analysis
    TradingView [COMMENT]
  74. Applied Materials shares slide as chip equipment outlook remains uncertain
    Investing.com - news 2 itemsalso Investing.com - UK
  75. Pinterest Stock Flashing Sell Signal Right Now
    Schaeffer's Research [COMMENT]
  76. Form 4 Tesla Inc For: 13 October
    Investing.com - UK 4 items
  77. GBPJPY SHORT POSITION
    TradingView [COMMENT]
  78. European stocks fall as U.S. bank earnings roll in
    Investing.com - news 2 itemsalso Investing.com - UK
  79. Maruti
    TradingView [COMMENT]